TG Therapeutics
TGTX
TGTX
240 hedge funds and large institutions have $4.76B invested in TG Therapeutics in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 89 increasing their positions, 76 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $5.19B → $4.76B (-$434M)
10% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 48
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Holders
240
Holding in Top 10
6
Calls
$69.5M
Puts
$76.3M
Top Buyers
| 1 | +$151M | |
| 2 | +$111M | |
| 3 | +$42.9M | |
| 4 |
BlackRock
New York
|
+$35.7M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$19.2M |
Top Sellers
| 1 | -$195M | |
| 2 | -$44.2M | |
| 3 | -$34.5M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$32.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$28.9M |